Response to Circular Economy Act

5 Nov 2025

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) 1107/2009, Regulation (EC) No 396/2005, Regulation (EU) 528/2012, Regulation (EC) 1831/2003, Regulation (EC) No 852/2004, Regulation (EC) No 853/2004, Regulation 1099/2009, Regulation (EC) No 999/2001, Regulation (EC) No 1069/2009, Regulation (EU) 2017/625 and Directive 98/58/EC, as regards simplifying and clarifying food and feed safety requirements

13 Oct 2025

Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices as regards simplification and burden reduction

6 Oct 2025

Response to Regulation of the European Parliament and of the Council establishing a framework of measures for strengthening Europe’s innovation ecosystem

2 Oct 2025

Meeting with Kristin Schreiber (Director Internal Market, Industry, Entrepreneurship and SMEs) and 1 other attendee

3 Sept 2025 · Attitudes towards food biotechnology

Meeting with Klaus Berend (Director Health and Food Safety), Rainer Becker (Director Health and Food Safety) and 1 other attendee

17 Jul 2025 · EU Biotech Act

Meeting with Tiemo Wölken (Member of the European Parliament, Shadow rapporteur)

8 Jul 2025 · Critical Medicines Act

Meeting with Eero Heinäluoma (Member of the European Parliament)

7 Jul 2025 · Discussion on Bioindustries

Response to Legislative proposal for a Regulation of the European Parliament and of the Council on the Industrial Decarbonisation Accelerator Act

4 Jul 2025

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

4 Jul 2025

Response to Communication on a new EU Bioeconomy strategy: Towards a Circular, Regenerative and Competitive Bioeconomy

23 Jun 2025

Meeting with Olivér Várhelyi (Commissioner) and 3 other attendees

17 Jun 2025 · EU biotech policy

Meeting with Patricia Reilly (Cabinet of President Ursula von der Leyen)

12 Jun 2025 · to follow

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

10 Jun 2025

Meeting with Marc Lemaitre (Director-General Research and Innovation) and 3 other interest representatives

4 Jun 2025 · 2nd dialogue with representatives from across the life sciences to review the progress of the IHI, to discuss opportunities to optimise the current partnership and to exchange views on the future of EU research and innovation programmes.

Response to Apply AI Strategy: strengthening the AI continent

3 Jun 2025

Meeting with Ekaterina Zaharieva (Commissioner) and 1 other attendee

3 Jun 2025 · Life sciences

Meeting with Pernille Weiss-Ehler (Cabinet of Commissioner Jessika Roswall)

26 May 2025 · The Water Resilience Strategy and the upcoming, updated Bioeconomy Strategy

Meeting with Olivér Várhelyi (Commissioner) and 2 other attendees

20 May 2025 · EU biotech policy

Meeting with Olivier Chastel (Member of the European Parliament, Shadow rapporteur)

15 May 2025 · Biotech - Politique de santé de l'UE

Meeting with Rainer Becker (Director Health and Food Safety)

13 May 2025 · Patient BioForum (event hosted by MEP Andras Tivadar Kulja)

Meeting with Stine Bosse (Member of the European Parliament)

8 May 2025 · Biotech policy

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

16 Apr 2025

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs) and 29 other attendees

10 Apr 2025 · Impact of US tariffs

Meeting with Stéphane Séjourné (Executive Vice-President) and 28 other attendees

10 Apr 2025 · Impact of US tariffs

Meeting with Eero Heinäluoma (Member of the European Parliament, Shadow rapporteur) and Fresenius SE & Co.KGaA

27 Mar 2025 · Biotech and Biomanufacturing

Meeting with Morten Løkkegaard (Member of the European Parliament, Shadow rapporteur)

25 Mar 2025 · Biotechnology

Response to Targeted evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostics

20 Mar 2025

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: European Start-up and Scale-up Strategy

14 Mar 2025

Meeting with Stine Bosse (Member of the European Parliament) and Confederation of Danish Industry

14 Mar 2025 · European health policy

Response to Evaluation of Directive 2014/23/EU on the award of concessions contracts, Directive 2014/24/EU on public procurement, and Directive 2014/25/EU on procurement by entities operating in the water, energy, transport and postal services sectors

7 Mar 2025

Meeting with Stine Bosse (Member of the European Parliament)

6 Mar 2025 · Life sciences and biotech policy

Meeting with Rainer Becker (Director Health and Food Safety)

6 Mar 2025 · Exchange of views on the Biotech Act

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

4 Mar 2025 · Bioeconomy, Biotech

Meeting with Stine Bosse (Member of the European Parliament)

27 Feb 2025 · European health policy

Meeting with Hildegard Bentele (Member of the European Parliament, Rapporteur) and 4 other interest representatives

27 Feb 2025 · Biotech

Response to Critical Medicines Act

26 Feb 2025

Meeting with Ilaria Flores Martin (Cabinet of Commissioner Jessika Roswall), Jan Ceyssens (Cabinet of Commissioner Jessika Roswall), Paulina Dejmek Hack (Cabinet of Commissioner Jessika Roswall)

24 Feb 2025 · linkages between Commissioner’s portfolio area and the bioindustry

Meeting with Elisa Roller (Director Secretariat-General)

21 Feb 2025 · Exchange of views on initiatives that will have an impact on the biotechnology sector like the Competitiveness Compass, Clean Industrial Deal, the Pharmaceutical Package, the Critical Medicines Act, the New Genomic Techniques proposal or the Biotechn

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... on laying down rules for the application of Regulation (EU) 2024/1735 of the European Parliament and of the Council as regards the list of net-zero technology final products and their main specific components for the purposes of assessing the contribution to resilience

20 Feb 2025

Meeting with Stine Bosse (Member of the European Parliament)

11 Feb 2025 · Life sciences and biotech policy

Meeting with Eero Heinäluoma (Member of the European Parliament, Shadow rapporteur)

11 Feb 2025 · Biotech

Response to Single Market Strategy 2025

30 Jan 2025

Meeting with Biljana Borzan (Member of the European Parliament)

28 Jan 2025 · Biotechnology across the 2025-2029

Meeting with András Tivadar Kulja (Member of the European Parliament)

24 Jan 2025 · Patient-centric and future proof regulatory framework in healthcare

Meeting with Eszter Lakos (Member of the European Parliament)

24 Jan 2025 · Biotechnology policy

Meeting with Anna Strolenberg (Member of the European Parliament)

4 Dec 2024 · Biotechnology in food and agriculture

Meeting with Stefan Köhler (Member of the European Parliament) and Zentralverband des Deutschen Handwerks e.V.

5 Nov 2024 · Politischer Austausch

Meeting with András Tivadar Kulja (Member of the European Parliament)

31 Oct 2024 · Biotechnology industry challanges

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

28 Oct 2024

Meeting with Bruno Tobback (Member of the European Parliament)

26 Sept 2024 · Nieuw Genomische Technieken (NGTs) en wasmiddelen

Meeting with Eszter Lakos (Member of the European Parliament) and European Federation of Pharmaceutical Industries and Associations

25 Sept 2024 · Public health

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

30 Apr 2024 · Presentatiion of EuropaBio study ‘Impact of the EU's General Pharmaceutical Legislation on Europe’s innovation ecosystem and biotechnology companies’ and to request a meeting

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

29 Mar 2024

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

29 Feb 2024

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 2 other interest representatives

22 Jan 2024 · Directive on Medicinal products for human use

Meeting with Martin Hojsík (Member of the European Parliament, Shadow rapporteur)

8 Nov 2023 · Detergents regulation, biotechnology

Meeting with Juozas Olekas (Member of the European Parliament, Shadow rapporteur for opinion)

7 Nov 2023 · New plant breeding techniques

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on plants obtained by certain new genomic techniques and their food and feed, and amending Regulation (EU) 2017/625

31 Oct 2023

Meeting with Tom Berendsen (Member of the European Parliament)

24 Oct 2023 · Speaker at plenary opening of European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Merck

11 Oct 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

9 Oct 2023

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

26 Sept 2023

Meeting with Jan Huitema (Member of the European Parliament, Shadow rapporteur) and Deutscher Bauernverband

26 Sept 2023 · New Genomic Techniques

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and European Patients' Forum (EPF)

20 Sept 2023 · Pharmaceutical legislation

Meeting with José Manuel Fernandes (Member of the European Parliament, Rapporteur)

7 Sept 2023 · STEP

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on compulsory licensing for crisis management and amending Regulation (EC) 816/2006

28 Jul 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on detergents and surfactants, amending Regulation (EU) 2019/1020 and repealing Regulation (EC) No 648/2004

26 Jul 2023

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

4 Jul 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on establishing a framework of measures for strengthening Europe’s net-zero technology products manufacturing ecosystem (Net Zero Industry Act)

27 Jun 2023

Meeting with Pernille Weiss-Ehler (Member of the European Parliament)

12 May 2023 · Resolution on EU action to combat antimicrobial resistance

Response to COMMISSION DELEGATED REGULATION (EU) …/... supplementing Regulation (EU) 2020/852 of the European Parliament and of the Council by establishing the technical screening criteria for determining the conditions under which an economic activity qualifies as contributing substantially to the sustainable use and protection of water and marine resources, to the transition to a circular economy, to pollution prevention and control, or to the protection and restoration of biodiversity and ecosystems and for determining whether that economic activity causes no significant harm to any of the other environmental objectives and amending Delegated Regulation (EU) 2021/2178 as regards specific public disclosures for those economic activities

3 May 2023

Meeting with Jörgen Warborn (Member of the European Parliament)

12 Apr 2023 · Läkemedelsstrategin - SMEs

Meeting with Pierre-Arnaud Proux (Cabinet of Executive Vice-President Margrethe Vestager), Stina Soewarta (Cabinet of Executive Vice-President Margrethe Vestager)

22 Mar 2023 · Pharmaceutical package, biopharma

Meeting with Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis) and 2 other interest representatives

6 Mar 2023 · Pharma package

Meeting with Simeona Manova (Cabinet of Commissioner Elisa Ferreira)

16 Feb 2023 · Presentation of a cross-sector Biomanufacturing Platform

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

25 Oct 2022 · Exchange of views on the upcoming reform of the pharmaceutical legislation

Meeting with Susana Solís Pérez (Member of the European Parliament, Shadow rapporteur)

7 Oct 2022 · EHDS

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC

7 Sept 2022

Response to Commission Communication on a new European Innovation Agenda

10 May 2022

Response to Proposal for a Directive on protecting, sustainably managing and restoring EU soils - Soil Health Law

15 Mar 2022

Response to COMMISSION REGULATION (EU) …/… amending Annex II to Regulation (EC) No 1107/2009 as regards specific criteria for the approval of active substances that are micro-organisms

23 Nov 2021

Response to Commission Communication on a policy framework for biobased, biodegradable and compostable plastics

27 Oct 2021

Response to Proposal for a Regulation of the European Parliament and of the Council establishing an EU framework for a Union sustainable food system

26 Oct 2021

Response to Restoring a Sustainable Carbon Cycle Communication on the Carbon Removal Certification Initiative and the Carbon Farming Initiative

4 Oct 2021

Response to Commission Report to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the regions on the European Bioeconomy Policy, Stocktaking and future developments

26 Aug 2021

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to COMMISSION DELEGATED REGULATION (EU) …/... supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with regard to the cases and conditions under which competent authorities may designate official laboratories which do not fulfil the conditions in relation to all the methods they use for official controls or other official activities

16 Apr 2021

Meeting with Margaritis Schinas (Vice-President) and 21 other attendees

8 Apr 2021 · Health Union

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

4 Mar 2021 · New Europa Bio Director-General Dr. Claire Skentelbery, and new Chair of the Board Andrew Topen, wish to introduce themselves to Director-General Kerstin Jorna and hear DG GROW’s priorities, to see where EuropaBio could potentially assist.

Response to Proposal for a Regulation of the European Parliament and of the Council establishing a European Health Emergency Response Authority (HERA)

24 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

3 Feb 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to COMMISSION DELEGATED REGULATION (EU) …/... supplementing Regulation (EU) 2020/852 of the European Parliament and of the Council by establishing the technical screening criteria for determining the conditions under which an economic activity qualifies as contributing substantially to climate change mitigation or climate change adaptation and for determining whether that economic activity causes no significant harm to any of the other environmental objectives

17 Dec 2020

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides)

24 Sept 2020 · Exchange of views on the upcoming pharmaceutical strategy

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions "Making the most of EU’s innovative potential - An Intellectual Property action plan in support of the EU’s industrial competitiveness"

12 Aug 2020

Response to Commission Communication on the future of research and innovation and the European Research Area

31 Jul 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

23 Jun 2020 · EuropaBio raises their concerns on the industrial strategy should inform the recovery; how industrial biotechnology and life science contribute to the Green Deal, competitiveness of industrial value chains and global level playing field

Response to Chemicals strategy for sustainability

19 Jun 2020

Response to Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social Committee and the Committee of the Regions on the Farm to Fork Strategy for a Sustainable Food System

15 Mar 2020

Meeting with Irena Joveva (Member of the European Parliament)

12 Feb 2020 · Bio production in Europe

Meeting with Dara Murphy (Cabinet of Commissioner Mariya Gabriel)

27 Jan 2020 · Future of European Bio Industries

Meeting with Tom Tynan (Cabinet of Commissioner Phil Hogan)

22 Jan 2020 · Business discussion

Response to Communication on a new Circular Economy Action Plan

20 Jan 2020

Meeting with Anne Bucher (Director-General Health and Food Safety)

9 Sept 2019 · discussion around bio pharmaceutical development and how to maintain the strength of this sector

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

4 Sept 2019 · Science based decision making. New biotechnologies

Meeting with Timo Pesonen (Acting Director-General Internal Market, Industry, Entrepreneurship and SMEs)

10 Jul 2019 · Courtesy meeting to introduce themselves and present their priorities

Meeting with Jean-Eric Paquet (Director-General Research and Innovation)

23 Apr 2019 · R&I in Biotechnology

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis) and 2 other interest representatives

12 Mar 2019 · GMO import approvals and new breeding techniques

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis)

12 Oct 2018 · Introductory meeting with the new SG

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the transparency and sustainability of the EU risk assessment in the food chain amending Regulation (EC) No 178/2002 [on general food law], Directive 2001/18/EC [on the deliberate release into the environment of GMOs], Regulation (EC) No 1829/2003 [on GM food and feed], Regulation (EC) No 1831/2003 [on feed additives], Regulation (EC) No 2065/2003 [on smoke flavourings], Regulation (EC) No 1935/2004 [on food contact materials], Regulation (EC) No 1331/2008 [on the common authorisation procedure for food additives, food enzymes and food flavourings], Regulation (EC) No 1107/2009 [on plant protection products] and Regulation (EU) No 2015/2283 [on novel foods]

22 Jun 2018

Meeting with Vytenis Andriukaitis (Commissioner) and 10 other attendees

15 Jun 2018 · HTA

Meeting with Michael Hager (Cabinet of Vice-President Günther Oettinger)

18 May 2018 · SPC manufacturing waiver

Meeting with Tom Tynan (Cabinet of Commissioner Phil Hogan)

25 Apr 2018 · Business discussion

Meeting with Leila Fernandez-Stembridge (Cabinet of Commissioner Pierre Moscovici)

10 Apr 2018 · IP regime generic manufacturers in the pharmaceutical industry

Response to Communication from the Commission updating the 2012 European Bioeconomy Strategy

19 Mar 2018

Meeting with Robert Schröder (Cabinet of Commissioner Carlos Moedas)

23 Jan 2018 · Update of the Bioeconomy strategy

Response to Commission Proposal for a Regulation on transparency and sustainability of the EU food and feed safety risk assessment model amending Regulation (EC) No 178/2002 Regulation (EC) No 178/2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety; and Directive 2001/18/EC on the deliberate release into the environment of GMOs, Regulation (EC) No 1829/2003 on GM food and feed, Regulation (EC) No 1831/2003 on feed additives, Regulation (EC) No 2065/2003 on smoke flavourings, Regulation (EC) No 1935/2004 on food contact materials, Regulation (EC) No 1331/2008 on the common authorisation procedure for food additives, food enzymes and food flavourings, Regulation (EC) No 1107/2009 on plant protection products and Regulation (EU) No 2015/2283 on novel foods.

17 Jan 2018

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis)

11 Jan 2018 · Discussion on future EuropaBio events

Response to COMMISSION REGULATION (EU) …/… amending Regulation (EC) No 847/2000 as regards the definition of the concept 'similar medicinal product'

27 Nov 2017

Meeting with Dermot Ryan (Cabinet of Commissioner Phil Hogan), Dermot Ryan (Cabinet of Commissioner Phil Hogan), Dermot Ryan (Cabinet of Commissioner Phil Hogan)

29 Aug 2017 · GMO import authorization process including several dossiers pending Commission authorization (following recent appeal committee votes), EC proposal to change comitology rules , Debate around the legal status of New Plant Breeding Techniques including genome editing

Meeting with Giulia Del Brenna (Cabinet of Commissioner Carlos Moedas)

24 Aug 2017 · Introduction of the New Secretary General

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis)

13 Jul 2017 · Introductory meeting of EuropaBio's new Secretary General

Response to COMMISSION DIRECTIVE (EU) .../… amending Directive 2001/18/EC of the European Parliament and of the Council as regards the environmental risk assessment of genetically modified organisms

29 Nov 2016

Meeting with Vytenis Andriukaitis (Commissioner) and 14 other attendees

17 Nov 2016 · Roundtable on the future of the General Food Law Regulation

Response to COMMISSION REGULATION (EU) No …/.. amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

12 Oct 2016

Meeting with Vytenis Andriukaitis (Commissioner) and 7 other attendees

27 Jun 2016 · New breeding techniques, innovation in seeds

Meeting with Xavier Prats Monné (Director-General Health and Food Safety)

7 Dec 2015 · Health and food aspect of biotech

Meeting with Lowri Evans (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

21 Oct 2015 · current challenges for the biotech industry

Meeting with Kaius Kristian Hedberg (Cabinet of Commissioner Elżbieta Bieńkowska)

16 Jul 2015 · Biotechnology Industry

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology) and JOŽE TRONTELJ INSTITUTE FOR ETHICS AND VALUES

8 Jul 2015 · Digital Publishing

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

23 Jun 2015 · Participation of Commissioner at event

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

2 Mar 2015 · Healthcare (personalised medicine which will be a priority of the LU Presidency, Biosimilars, Advanced Therapy Medicinal Products (ATMPs), Health Technology Assessment (HTA) and GMO'S

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology)

17 Feb 2015 · Health and JCJ Goals

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology) and 11 other interest representatives

12 Feb 2015 · Digital Single Market, Innovation

Meeting with Jyrki Katainen (Vice-President) and 1 other attendee

3 Feb 2015 · Bioeconomy

Meeting with Carlos Moedas (Commissioner) and 7 other interest representatives

2 Feb 2015 · Meeting with the European Bioeconomy Alliance on the Bioeconomy Strategy

Meeting with Ladislav Miko (acting Director-General Health and Food Safety)

21 Jan 2015 · GMO

Meeting with Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

14 Jan 2015 · Meeting with Introductory meeting w. Europabio to discuss the biotechnology industry in Europe (healthcare, agri-food and bioeconomy/industrial biotechnology field)

Meeting with Heidi Jern (Cabinet of Vice-President Jyrki Katainen)

14 Jan 2015 · Bioindustries and biotechnology

Meeting with Shane Sutherland (Cabinet of Commissioner Phil Hogan)

10 Dec 2014 · Biotechnology

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

9 Dec 2014 · Preparation of Commissioner's participation to future Europabio event, personalised medicines; GMOs.

Meeting with Ladislav Miko (acting Director-General Health and Food Safety)

5 Dec 2014 · New transparency rules and pending GM authorisations